INFINITY PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2011 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Infinity Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2011 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 89.9M shares, a 0.81% increase year-over-year.
  • Infinity Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 89.2M shares, a 4.27% increase from 2021.
  • Infinity Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 85.6M shares, a 43% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 89.9M +724K +0.81% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 89.4M +258K +0.29% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 89.2M +3.65M +4.27% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 89.4M +625K +0.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 89.2M +500K +0.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 89.2M +13.4M +17.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 85.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 88.8M +28.3M +46.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 88.7M +31.2M +54.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 75.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2020 60.5M +3.48M +6.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 57.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q3 2019 57M +177K +0.31% Jul 1, 2019 Sep 30, 2019 10-Q 2019-10-30
Q3 2018 56.9M +6.22M +12.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q3 2017 50.6M +1.05M +2.12% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 50.5M +1.02M +2.06% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-03
Q4 2016 50.1M +871K +1.77% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 49.6M +395K +0.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 49.4M +361K +0.74% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 49.3M +401K +0.82% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 49.2M +439K +0.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 49.2M +556K +1.14% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 49.1M +532K +1.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 48.9M +591K +1.22% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 48.8M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 48.6M +580K +1.21% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-23
Q2 2014 48.5M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-23
Q1 2014 48.3M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-23
Q3 2013 48.1M +16M +50% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q4 2012 40.9M Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 32M +5.37M +20.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 27.1M Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 26.8M Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q3 2011 26.7M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.